Therefore, this study aimed to evaluate the roles of Oment-1 and MALAT1 in CHD among T2DM patients and to explore the potential roles of Oment-1, MALAT1 and their combination as specific noninvasive markers for CHD in T2DM patients. This evidence concerns the gene MALAT1 and type 2 diabetes mellitus.